Briefing: Can a psychedelic ‘coach’ make ketamine therapy even more effective?
Strategic angle: A new study explores whether incorporating psychotherapy with ketamine treatment enhances its effectiveness.
Editorial Staff Apr 1
Briefing: Opinion: Medical marijuana should not be recommended for PTSD, anxiety, or depression
Strategic angle: “Rigorously derived evidence for the medical efficacy of marijuana is thin,” writes Kevin Sabet.
Editorial Staff Apr 1
Briefing: 'My six-year-old has nosebleeds': Chiang Mai air pollution sparks health fears
Strategic angle: It's peak fire season in the Thai city, which now ranks as one of the world's most polluted.
Editorial Staff Apr 1
Briefing: 'One Plant Health Concept' connects tradition and technology to address plant diseases in Africa
Strategic angle: An article published in CABI Agriculture and Bioscience advocates for a diverse approach combining indigenous knowledge and modern technologies to combat plant diseases in Africa.
Editorial Staff Apr 1
Briefing: SimCells successfully target and kill drug-resistant bacteria
Strategic angle: A breakthrough in the fight against superbugs and antimicrobial resistance.
Editorial Staff Mar 31
Briefing: The wellness world is eager for RFK Jr.'s promised move on peptides
Strategic angle: Health Secretary Kennedy's upcoming decision on peptides could reshape the wellness industry.
Editorial Staff Mar 31
Briefing: HHS Renames U.S. Health IT Office
Strategic angle: The Trump administration reverts the name of the federal health IT office to the Office of the National Coordinator.
Editorial Staff Mar 31
Briefing: Overview of President Trump’s Executive Actions on Global Health
Strategic angle: This guide provides an overview of executive orders and other executive actions made by the Trump Administration since January 21, 2025 that directly address or affect U.S. global health efforts.
Editorial Staff Mar 31
Briefing: Why the Street Isn’t Bullish on Omega Healthcare Investors, Inc. (OHI) – Yet
Strategic angle: An analysis of the current market sentiment surrounding Omega Healthcare Investors, Inc.
Editorial Staff Mar 31
Briefing: STAT+: OpenEvidence inks deal with major health system
Strategic angle: OpenEvidence partners with a significant health system to enhance health record sharing.
Editorial Staff Mar 31
Briefing: Pharma Delays Launches in Europe Amid U.S. Pressure
Strategic angle: Drugmakers are postponing the release of new medicines in Europe due to shifting pricing policies and pressures from the U.S.
Editorial Staff Mar 31
Briefing: A new survey examines mental health outcomes of gender euphoria
Strategic angle: Lead exposure and heart disease, promoting psychedelics on YouTube, and other health news from Morning Rounds
Editorial Staff Mar 31
Briefing: Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive
Strategic angle: Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive
Editorial Staff Mar 31
Briefing: Opinion: How the next CDC director can win back America’s trust
Strategic angle: “The CDC stands at an inflection point,” write Charles J. Lockwood, Robert C. Gallo, and Sten H. Vermund.
Editorial Staff Mar 31
Briefing: Your post-gym protein shake may get a taste upgrade: Manufacturing can improve whey protein drink palatability
Strategic angle: New research suggests that the taste and texture of protein shakes can be enhanced by modifying whey protein production methods.
Editorial Staff Mar 31
Briefing: Scientists discover sleep switch that builds muscle, burns fat, and boosts brainpower
Strategic angle: Deep sleep activates a brain-driven system that enhances growth hormone, impacting muscle strength, metabolism, and mental performance.
Editorial Staff Mar 31
Briefing: Unilever nears deal to combine food division with spice maker McCormick
Strategic angle: Move will transform Hellmann’s mayonnaise maker from multi-category conglomerate into beauty and personal care company
Editorial Staff Mar 30
Briefing: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting
Strategic angle: Takeda Pharmaceuticals, the largest biopharma employer in Mass., will lay off 250 workers in Cambridge beginning in July.
Editorial Staff Mar 30
Briefing: Portable unit can quickly detect deadly whale and dolphin diseases
Strategic angle: Novel marine mammal health surveillance can now detect deadly diseases in whales and dolphins in oceans, beaches and remote locations.
Editorial Staff Mar 30
Briefing: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug
Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir.
Editorial Staff Mar 30